首页> 外国专利> In vitro diagnostic and prognosis of major adverse events in patients undergoing coronary angiography

In vitro diagnostic and prognosis of major adverse events in patients undergoing coronary angiography

机译:冠状动脉造影患者主要不良事件的体外诊断和预后

摘要

Method of diagnosis and prognosis of contrast media induced nephropathy (CIN) including the steps of i) taking a urine sample from a patient exposed to the application of contrast media, notably patients subjected to coronary angiography; ii) assessing the level of vitamin D binding protein (VDBP) in the urine sample obtained in step (i); iii) relating the urinary vitamin D binding protein level determined in step (ii) to a pre-selected threshold level. A urinary vitamin D binding protein level higher than the pre-selected threshold level indicates that the patient is at risk of renal failure and in need of a dialysis treatment.
机译:造影剂诱发的肾病(CIN)的诊断和预后方法包括以下步骤:i)从暴露于造影剂应用的患者(尤其是接受冠状动脉造影的患者)中获取尿液样本; ii)评估步骤(i)中获得的尿液样品中维生素D结合蛋白(VDBP)的水平; iii)将步骤(ii)中确定的尿中维生素D结合蛋白水平与预选的阈值水平相关。尿中维生素D结合蛋白的水平高于预先选择的阈值水平,表明该患者有肾功能衰竭的风险,需要透析治疗。

著录项

  • 公开/公告号US9823258B2

    专利类型

  • 公开/公告日2017-11-21

    原文格式PDF

  • 申请/专利权人 IMMUNDIAGNOSTIK AG;

    申请/专利号US201515120157

  • 发明设计人 BERTHOLD HOCHER;FRANZ PAUL ARMBRUSTER;

    申请日2015-02-20

  • 分类号G01N31/00;G01N33/53;G01N33/68;G01N33/70;G01N33/82;

  • 国家 US

  • 入库时间 2022-08-21 12:55:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号